Loyal
CompanyLoyal, a San Francisco, CA-based clinical-stage animal health company, raised $22M in B-2 funding. The round, in addition to its $45M Series B in 2024, was led by Valor Equity Partners and Collaborative Fund, among others.
Date
Feb 26, 2025
Category
biotech
Lead investor
Collaborative Fund
Stage
Series B
Size
$22M
General Catalyst
Accel
Bessemer Venture Partners
HubSpot Ventures
QED
Menlo Ventures
20VC
Upfront Ventures
a16z
J.P. Morgan
Breega
BOND Capital